Home > Insider Trading > Filing (0001209191-23-013765)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1789815	Ourania Tatsis	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Chief Reg. & Quality Off.	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-02-24	3,308	$289.12	57,159	No	4	F	Direct
Common Stock	Disposition	2023-02-27	283	$287.20	56,876	No	4	S	Direct
Common Stock	Disposition	2023-02-27	51	$288.33	56,825	No	4	S	Direct
Common Stock	Disposition	2023-02-27	20	$289.29	56,805	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Ms. Tatsis' company approved trading plan under Rule 10b5-1.
Ms. Tatsis undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $287.20 (range $286.71 to $287.60).
Open market sales reported on this line occurred at a weighted average price of $288.33 (range $287.82 to $288.74).
Open market sales reported on this line occurred at a weighted average price of $289.29 (range $289.17 to $289.40).